Artificial Retina Market Size 2024-2028
The artificial retina market size is forecast to increase by USD 8.59 billion at a CAGR of 11.6% between 2023 and 2028.
- The market is experiencing significant growth due to the increasing prevalence of retinal diseases. The rise in the number of patients suffering from conditions such as age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa is driving market growth. Additionally, escalating investments in ophthalmological research and development and innovations in artificial retina technology are contributing to market expansion. Cell therapy, including stem cell therapy, is also being explored for its potential to replace damaged photoreceptor cells and improve image quality. However, the market faces challenges from a stringent regulatory framework and high costs associated with these advanced medical devices. Despite these hurdles, the market is expected to witness steady growth due to the unmet medical needs and the potential for technological advancements.
What will be the Size of the Artificial Retina Market During the Forecast Period?
- The market encompasses innovative technologies designed to restore vision for individuals suffering from various retinal diseases, such as retinitis pigmentosa and age-related macular degeneration. These advanced solutions replace or enhance damaged photoreceptors in the retina, converting electrical signals into perceptible vision. Microchip-based retinal implants transmit electrical stimulation to the optic nerve, bypassing the damaged retina. Indications include not only ocular diseases like glaucoma and diabetic retinopathy but also optic nerve diseases. Technological advancements in this sector include energy sources, minimizing infection risk, and improving image resolution. Companies are exploring the use of stem cells and gene therapy to regenerate damaged retinal tissue.
- Some solutions offer color perception, while others remain black and white. Second Sight's Argus II Retinal Prosthesis System is an example of a successful commercial product in this field. Future trends include integrated cameras, retinal problems with non-damaged optic nerves, and the potential application of electrical stimulation for end-stage glaucoma and retinal diseases. As research continues, advancements in energy sources, infection risk reduction, and image resolution will further drive market growth.
How is this Artificial Retina Industry segmented and which is the largest segment?
The artificial retina industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
- Disease Type
- Macular degeneration
- Diabetic retinopathy
- Geography
- North America
- Canada
- US
- Europe
- Germany
- France
- Spain
- Asia
- Rest of World (ROW)
- North America
By Disease Type Insights
- The macular degeneration segment is estimated to witness significant growth during the forecast period.
Macular degeneration, a degenerative eye condition, affects the macula, the central part of the retina responsible for sharp, central vision. The most common forms are age-related macular degeneration (AMD) and Stargardt disease. AMD is diagnosed as either dry or wet, with dry AMD being the more prevalent form, affecting approximately 80% of patients. Dry AMD results from the aging and thinning of macular tissues or the depositing of pigments in the macula. Currently, there are no approved therapies from the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA) for treating dry AMD. Advanced macular degeneration can lead to vision loss and blindness, highlighting the need for innovative treatments.
Artificial retinas, such as those developed by Alpha AMS and Retinal Implant AG, offer potential solutions by replacing damaged photoreceptor cells with electronic ones. These devices convert electrical signals from the retina into optical impulses that stimulate the optic nerve, enabling vision. However, challenges include infection risk, image resolution, surgical risks, inorganic material integration, scarring tissues, and nervous stimuli transmission. Future research may explore cell therapy, gene therapy, and integrated cameras to improve image quality and vision restoration, offering partial vision recovery for those with retinal problems, including optic nerve diseases, end-stage glaucoma, and retinal diseases.
Get a glance at the Artificial Retina Industry report of share of various segments Request Free Sample
The Macular degeneration segment was valued at USD 6 billion in 2018 and showed a gradual increase during the forecast period.
Regional Analysis
- North America is estimated to contribute 42% to the growth of the global market during the forecast period.
Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions, Request Free Sample
The North American region dominates The market, with the US and Canada holding a significant market share. The US is the primary contributor to this regional growth, driven by a high prevalence of retinal disorders and increased public awareness. The aging population in the US, which is at a higher risk for retinal diseases such as RVO and advanced AMD, is a significant factor fueling market expansion. Key indications in the market include retinitis pigmentosa, glaucoma, and diabetic retinopathy. Technologies such as Alpha AMS, Retinal Implant AG, Microchip, and Second Sight are employed to restore vision by stimulating the optic nerve with electrical signals.
Integration of inorganic materials, infection risk, surgical risks, and image resolution are critical challenges. Research in areas such as stem cells, gene therapy, and energy sources continues to progress, offering potential treatment alternatives for various retinal problems, including non-damaged optic nerve diseases and end-stage glaucoma.
Market Dynamics
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the key market drivers leading to the rise in the adoption of Artificial Retina Industry?
The rise in the prevalence of retinal diseases is the key driver of the market.
- The market encompasses innovative technologies designed to address various retinal diseases, including Retinitis Pigmentosa, Glaucoma, and Diabetic Retinopathy. Companies are pioneering advancements in this field, focusing on microchip-based retina implants that convert electrical signals from the retina into optical impulses, bypassing damaged photoreceptors and stimulating the optic nerve for vision. These implants offer the potential for both black and white and color perception, indicating various ocular diseases. However, challenges persist, including infection risk, image resolution, surgical risks, and inorganic material integration. Research progress includes stem cell therapy, gene therapy, and Luxturna, which employs gene therapy to restore vision in individuals with inherited retinal diseases.
- Electrical stimulation, integrated cameras, and electrode stimulation are other promising approaches for vision restoration and partial vision recovery. Despite these advancements, there are ongoing concerns regarding the safety and efficacy of these treatments. The prevalence of retinal diseases, such as wet AMD, diabetic retinopathy, and other retinal problems, continues to rise, with approximately 200,000 new cases being diagnosed in North America annually. As the need for effective treatment alternatives grows, so does the urgency for continued research and innovation in the market.
What are the market trends shaping the Artificial Retina Industry?
Escalating investment in ophthalmological research and development and innovations is the upcoming market trend.
- The market is witnessing significant advancements as various nations focus on combating blindness through innovative technologies. Conditions like Retinitis pigmentosa, glaucoma, and diabetic retinopathy are driving the demand for artificial retina solutions.
- Companies are pioneering the development of microchip-based retinas that convert electrical signals into nervous stimuli transmission, bypassing damaged photoreceptor cells in the retina. These retinal implants can restore vision in individuals with non-damaged optic nerves, offering partial vision recovery and improving image quality. Moreover, researchers are exploring alternative treatments, such as stem cell therapy and gene therapy, to address retinal problems. For instance, Luxturna, a gene therapy treatment for inherited retinal diseases, has shown promising results. However, challenges such as infection risk, image resolution, surgical risks, and inorganic material integration remain.
What challenges does the Artificial Retina Industry face during its growth?
A stringent regulatory framework is a key challenge affecting the industry's growth.
- The market faces regulatory challenges due to stringent testing requirements. Artificial retinas, which involve the use of microchips and electrical stimulation to restore vision in individuals with retinal diseases such as Retinitis pigmentosa, require extensive testing to ensure safety and efficacy. These solutions must be sterile until opened and undergo toxicology studies to identify any potential harm to the eye. Preclinical tests are conducted on rabbits to assess the safety of these devices. Any product that poses a risk to eye health is not permitted in the market.
- Other challenges include infection risk, image resolution, surgical risks, inorganic material integration, scarring tissues, and nervous stimuli transmission. Research and development efforts are ongoing to improve image quality, reduce surgical risks, and explore alternatives such as stem cell therapy and gene therapy. Energy sources and integration of an integrated camera are also areas of focus to enhance the functionality of artificial retinas. Despite these challenges, the market for artificial retinas continues to progress, offering hope for those with vision loss due to retinal diseases.
Exclusive Customer Landscape
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, artificial retina market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Aetna Inc.
- Alcon Inc.
- Bausch Lomb Corp.
- Bionic Eye Technologies Inc.
- Bionic Vision Technologies
- Carl Zeiss AG
- Nano Retina
- NIDEK Co. Ltd.
- Optobionics
- PIXIUM VISION
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Research Analyst Overview
Artificial retinas, also known as retinal implants, represent a promising solution for individuals suffering from various retinal diseases that lead to vision loss. These innovative devices are designed to replace the function of damaged or non-functioning photoreceptor cells in the retina. By converting light into electrical signals, these implants can stimulate the optic nerve and restore some level of vision. The global market is driven by the increasing prevalence of retinal diseases, such as retinitis pigmentosa, Glaucoma, and diabetic retinopathy. These conditions often result in the degeneration of photoreceptor cells, leading to vision loss.
Moreover, the growing aging population is also contributing to the market growth. Age is a significant risk factor for various retinal diseases, and as the population ages, the number of individuals requiring vision restoration solutions is expected to rise. Despite the promising potential of artificial retinas, the market faces several challenges. One of the primary challenges is the development of high-resolution implants. Current devices offer only black-and-white vision, which limits their usefulness in everyday life. Furthermore, the integration of inorganic materials into living tissues poses a risk of scarring and infection. Another challenge is the development of cost-effective and efficient manufacturing processes.
Furthermore, retinal implants are complex devices that require advanced manufacturing techniques and specialized materials. Reducing manufacturing costs while maintaining quality is a significant challenge for market players. The market for artificial retinas is also driven by research progress in various areas, including stem cell therapy, gene therapy, and energy sources. These emerging technologies offer the potential for more effective and efficient vision restoration solutions. Despite the challenges, the market is expected to grow significantly in the coming years. The increasing prevalence of retinal diseases, the aging population, and the development of new technologies are all driving the market forward.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
127 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 11.6% |
|
Market Growth 2024-2028 |
USD 8.59 billion |
|
Market structure |
Concentrated |
|
YoY growth 2023-2024(%) |
10.1 |
|
Key countries |
US, Germany, Spain, Canada, and France |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
What are the Key Data Covered in this Artificial Retina Market Research and Growth Report?
- CAGR of the Artificial Retina industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the artificial retina market growth of industry companies
We can help! Our analysts can customize this artificial retina market research report to meet your requirements.